Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
1por Lawton, GrahamEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2
-
3
-
4“…In efforts to combat the SARS-CoV-2, prompt response from Pfizer-BioNTech and Moderna lead to vaccine development with a novel method, synthesized from modified messenger RNA. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5por Lexchin, Joel“…Lexchin examines how Pfizer transformed sildenafil from an effective product for erectile dysfunction due to illness or injury into a drug that healthy men can use to enhance their erections.…”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
6por PRATAP SINGH, VIJAY, SIDDIQUE PIR, MUHAMMAD, BUCH, TAPAN, KAUR, AMANDEEP, KELA, KASHYAP, SHAH, PRINCY, MILLER, JACOB, NASEER, RAZA, GHOSH, PRADEEPTOEnlace del recurso
Publicado 2021
Enlace del recurso
Online Artículo Texto -
7por Aly, Mohammed H, Alshehri, Abdulrahman A, Mohammed, Abdelgaffar, Almalki, Abdulrahman M, Ahmed, Walaa A, Almuflihi, Alhanouf M, Alwafi, Atheer A“…This study presents the first case of the Pfizer vaccine associated with erythema nodosum. A 22-year-old healthy woman presented with a five-day history of several red painful areas with swelling in the lower extremities that started one day after receiving the first dose of Pfizer vaccine. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8por Siranosian, KathyEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9“…Herein, we report a rare case of Granulomatosis with polyangiitis (GPA) in an active duty military male soon after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10“…CONCLUSIONS: We found no indication for an increased risk for an acute cardiovascular event in the 30 days (compared to 31-60 days) following administration of the second vaccine dose of Pfizer COVID19 vaccine. KEY MESSAGES: • We found no indication for an increased risk for an acute cardiovascular event in the 30 days (compared to 31-60 days) following administration of the second vaccine dose of Pfizer COVID19 vaccine. • These findings did not change when sensitivity analyses were used.…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11
-
12
-
13
-
14
-
15
-
16por Lopez, Erick Daniel, Javed, Nismat, Upadhyay, Shubhra, Shekhar, Rahul, Sheikh, Abu Baker“…We report a 58-year-old man with a history of psoriasis and multiple comorbidities who presented with a worsening pruritic rash 1 week after receiving the COVID-19 Pfizer vaccine. He was treated with triamcinolone-based wet wraps, triamcinolone ointment, and hydroxyzine, which improved his rash significantly after 6 days of hospitalization.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
17“…We present a case of MFS following Pfizer COVID-19 vaccine. CASE PRESENTATION: A previously healthy 24-year-old female presented with binocular horizontal diplopia 18 days after receiving the first dose of Pfizer COVID-19 vaccine (Comirnaty®). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
18“…The current study aimed to assess the reactogenicity and immunogenicity of the Pfizer and AstraZeneca COVID-19 vaccines among adults in Madinah, Saudi Arabia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
19
-
20por Graeff, Daniela Bertol, Lui, Jéssica Maldaner, Zucco, Nathália Dal Prá, Alves, Ana Luisa Sant’Anna, Forcelini, Cassiano Mateus, Dalmolin, Bernadete Maria“…There was weak correlation of the scores with scholarity (Pfizer: r=0.283, p£0.001; Shulman: r=0.244, p£0.001) and age (Pfizer: r=-0.174, p£0.001; Shulman: r=-0.170, p£0.001). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto